Zobrazeno 1 - 10
of 142
pro vyhledávání: '"Amanda, Stebbins"'
Autor:
Guillaume Marquis‐Gravel, Amanda Stebbins, Lisa M. Wruck, Matthew T. Roe, Mark B. Effron, Bradley G. Hammill, Jeff Whittle, Jeffrey J. VanWormer, Holly R. Robertson, Jacqueline D. Alikhaani, Sunil Kripalani, Peter M. Farrehi, Saket Girotra, Catherine P. Benziger, Tamar S. Polonsky, J. Greg Merritt, Kamal Gupta, Thomas E. McCormick, Kirk U. Knowlton, Sandeep K. Jain, Ajar Kochar, Russell L. Rothman, Robert A. Harrington, Adrian F. Hernandez, W. Schuyler Jones
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 4 (2024)
Background In patients with atherosclerotic cardiovascular disease, increasing age is concurrently associated with higher risks of ischemic and bleeding events. The objectives are to determine the impact of aspirin dose on clinical outcomes according
Externí odkaz:
https://doaj.org/article/094387e244204d1ea7d8c9c34e5dcd36
Autor:
Saket Girotra, Amanda Stebbins, Lisa Wruck, Guillaume Marquis‐Gravel, Kamal Gupta, Peter Farrehi, Catherine P. Benziger, Mark B. Effron, Jeffrey Whittle, Daniel Muñoz, Sunil Kripalani, R. David Anderson, Sandeep K. Jain, Tamar S. Polonsky, Faraz S. Ahmad, Matthew T. Roe, Russell L. Rothman, Robert A. Harrington, Adrian F. Hernandez, W. Schuyler Jones
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 20 (2023)
Background The ADAPTABLE (Aspirin Dosing: A Patient‐Centric Trial Assessing Benefits and Long‐Term Effectiveness) was a large, pragmatic, randomized controlled trial that found no difference between high‐ versus low‐dose aspirin for secondary
Externí odkaz:
https://doaj.org/article/91da8deb544f41d98ac20c29a09e6535
Autor:
Tsuyoshi Kaneko, Sreekanth Vemulapalli, Shun Kohsaka, Kazuo Shimamura, Amanda Stebbins, Hiraku Kumamaru, Adam J. Nelson, Andrzej Kosinski, Koichi Maeda, Joseph E. Bavaria, Shigeru Saito, Michael J. Reardon, Toru Kuratani, Jeffrey J. Popma, Taku Inohara, Vinod H. Thourani, John D. Carroll, Hideyuki Shimizu, Morimasa Takayama, Martin B. Leon, Michael J. Mack, Yoshiki Sawa
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 6 (2022)
Background The practice pattern and outcome of medical devices following their regulatory approval may differ by country. The aim of this study is to compare postapproval national clinical registry data on transcatheter aortic valve replacement betwe
Externí odkaz:
https://doaj.org/article/44f5071606a24a2bbb656550c056e6ed
Autor:
Tanyanan Tanawuttiwat, Amanda Stebbins, Guillaume Marquis‐Gravel, Sreekanth Vemulapalli, Andrzej S. Kosinski, Alan Cheng
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 1 (2022)
Background Clinical evidence on the safety and effectiveness of using direct oral anticoagulants (DOACs) in patients with atrial fibrillation after transcatheter aortic valve replacement (TAVR) remains limited. The aim of this study was to investigat
Externí odkaz:
https://doaj.org/article/c1c3ecfab1a647d5b8fbe5c9a1962bea
Autor:
E Hope Weissler, Amanda Stebbins, Lisa Wruck, Daniel Muñoz, Kamal Gupta, Saket Girotra, Jeff Whittle, Catherine P Benziger, Tamar S Polonsky, Steven M Bradley, Bradley G Hammill, James G Merritt, Doris N Zemon, Adrian F Hernandez, W Schuyler Jones
Publikováno v:
Vascular Medicine. 28:122-130
Background: We aimed to understand the effects of aspirin dose on outcomes in patients with peripheral artery disease (PAD) as well as their participation in a pragmatic randomized controlled trial. Methods: In a subanalysis of the Aspirin Dosing: A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f2de316e38148369e671f60f464c5bd9
https://doi.org/10.1177/1358863x231154951
https://doi.org/10.1177/1358863x231154951
Autor:
Trevor Simard, Sreek Vemulapalli, Richard G. Jung, Andrew Vekstein, Amanda Stebbins, David R. Holmes, Andrew Czarnecki, Benjamin Hibbert, Mohamad Alkhouli
Publikováno v:
Journal of the American College of Cardiology. 80:2072-2084
Data on the efficacy of transcatheter edge-to-edge repair (TEER) in patients with cardiogenic shock (CS) are limited.This study investigated the characteristics and outcomes of consecutive patients with significant mitral regurgitation (MR) and CS wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b0b74be9035fb58e1465eeff0ce3d55
https://doi.org/10.1016/j.jacc.2022.09.006
https://doi.org/10.1016/j.jacc.2022.09.006
Autor:
Ralph A. H. Stewart, Claes Held, Sue Krug‐Gourley, Dawn Waterworth, Amanda Stebbins, Karen Chiswell, Emil Hagstrom, Paul W. Armstrong, Lars Wallentin, Harvey White
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 8, Iss 7 (2019)
Background Vascular risk factors have been associated with differences in cognitive performance in epidemiological studies, but evidence in patients with coronary heart disease is more limited. Methods and Results The Montreal Cognitive Assessment sc
Externí odkaz:
https://doaj.org/article/0867d6f57a9d49588b04100e233f20fe
Autor:
Javed, Butler, Amanda, Stebbins, Vojtěch, Melenovský, Nancy K, Sweitzer, Martin R, Cowie, Josef, Stehlik, Muhammad Shahzeb, Khan, Robert O, Blaustein, Justin A, Ezekowitz, Adrian F, Hernandez, Carolyn S P, Lam, Richard, Nkulikiyinka, Christopher M, O'Connor, Burkert M, Pieske, Piotr, Ponikowski, John A, Spertus, Adriaan A, Voors, Kevin J, Anstrom, Paul W, Armstrong
Publikováno v:
Circulation: Heart Failure, 15(6):E009337, 566-575. LIPPINCOTT WILLIAMS & WILKINS
Background: We examined the effects of vericiguat compared with placebo in patients with heart failure with reduced ejection fraction enrolled in VICTORIA (Vericiguat Global Study in Patients With Heart Failure With Reduced Ejection Fraction) on heal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb9f7ad97a5dca8ba8fc8e05bc6846b6
https://doi.org/10.1161/CIRCHEARTFAILURE.121.009337
https://doi.org/10.1161/CIRCHEARTFAILURE.121.009337
Vericiguat in patients with coronary artery disease and heart failure with reduced ejection fraction
Autor:
Clara, Saldarriaga, Dan, Atar, Amanda, Stebbins, Basil S, Lewis, Imran Zainal, Abidin, Robert O, Blaustein, Javed, Butler, Justin A, Ezekowitz, Adrian F, Hernandez, Carolyn S P, Lam, Christopher M, O'Connor, Burkert, Pieske, Piotr, Ponikowski, Lothar, Roessig, Adriaan A, Voors, Kevin J, Anstrom, Paul W, Armstrong
Publikováno v:
European Journal of Heart Failure, 24(5), 782-790. Wiley
Aims: Coronary artery disease (CAD) portends worse outcomes in heart failure (HF). We aimed to characterize patients with CAD and worsening HF with reduced ejection fraction (HFrEF) and evaluate post hoc whether vericiguat treatment effect varied acc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7044d3bfcc00e430fe4306650d8b0b72
https://hdl.handle.net/11370/bf31012c-be27-4e2d-a9a7-5bb9c7437df8
https://hdl.handle.net/11370/bf31012c-be27-4e2d-a9a7-5bb9c7437df8
Autor:
Aaron W. Aday, Marc D. Samsky, Adrian F. Hernandez, Robert J. Mentz, Rury R. Holman, W. Schuyler Jones, Neha J. Pagidipati, Amanda Stebbins, Manesh R. Patel, Yuliya Lokhnygina, Jorge Antonio Gutierrez, Brian G. Katona
Publikováno v:
Atherosclerosis
BACKGROUND AND AIMS: Polyvascular disease is an independent predictor of major adverse cardiovascular events (MACE). The relationship between the number of diseased arterial beds and MACE is unknown. How MACE risk changes in individuals with type 2 d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac92ceb6d99e75ed8d1972fc53bd1028
https://doi.org/10.1016/j.atherosclerosis.2021.10.011
https://doi.org/10.1016/j.atherosclerosis.2021.10.011